VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS20067231 | HPV | ENSG00000096968.14 | protein_coding | JAK2 | Yes | No | 3717 | O60674 |
TVIS20066328 | HPV | ENSG00000096968.14 | protein_coding | JAK2 | Yes | No | 3717 | O60674 |
TVIS20021822 | HPV | ENSG00000096968.14 | protein_coding | JAK2 | Yes | No | 3717 | O60674 |
TVIS20021828 | HPV | ENSG00000096968.14 | protein_coding | JAK2 | Yes | No | 3717 | O60674 |
TVIS20013251 | HPV | ENSG00000096968.14 | protein_coding | JAK2 | Yes | No | 3717 | O60674 |
TVIS20021829 | HPV | ENSG00000096968.14 | protein_coding | JAK2 | Yes | No | 3717 | O60674 |
TVIS20026486 | HPV | ENSG00000096968.14 | protein_coding | JAK2 | Yes | No | 3717 | O60674 |
TVIS20021821 | HPV | ENSG00000096968.14 | protein_coding | JAK2 | Yes | No | 3717 | O60674 |
TVIS20021824 | HPV | ENSG00000096968.14 | protein_coding | JAK2 | Yes | No | 3717 | O60674 |
TVIS20063911 | HPV | ENSG00000096968.14 | protein_coding | JAK2 | Yes | No | 3717 | O60674 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | JAK2 |
---|---|
DrugBank ID | DB12500 |
Drug Name | Fedratinib |
Target ID | BE0002408 |
UniProt ID | O60674 |
Regulation Type | inhibitor |
PubMed IDs | 21220608; 27473820 |
Citations | Pardanani A, Gotlib JR, Jamieson C, Cortes JE, Talpaz M, Stone RM, Silverman MH, Gilliland DG, Shorr J, Tefferi A: Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis. J Clin Oncol. 2011 Mar 1;29(7):789-96. doi: 10.1200/JCO.2010.32.8021. Epub 2011 Jan 10.@@Roskoski R Jr: Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. Pharmacol Res. 2016 Sep;111:784-803. doi: 10.1016/j.phrs.2016.07.038. Epub 2016 Jul 26. |
Groups | Approved; Investigational |
Direct Classification | Benzenesulfonamides |
SMILES | CC1=CN=C(NC2=CC=C(OCCN3CCCC3)C=C2)N=C1NC1=CC=CC(=C1)S(=O)(=O)NC(C)(C)C |
Pathways | |
PharmGKB | PA166280361 |
ChEMBL | CHEMBL1287853 |